PURE RED-CELL APLASIA FOLLOWING ABO MISMATCHED MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA - RESPONSE TO ANTITHYMOCYTE GLOBULIN

被引：20

作者：

BIERMAN, PJ

WARKENTIN, P

HUTCHINS, MR

KLASSEN, LW

机构：

[1] Departments of Internal Medicine, University of Nebraska Medical Center, Omaha

[2] Departments of Pathology/Microbiology, University of Nebraska Medical Center, Omaha

[3] Departments of Wedgewood, Medical Center, Lincoln, NE

来源：

LEUKEMIA & LYMPHOMA | 1993年 / 9卷 / 1-2期

关键词：

BONE MARROW TRANSPLANTATION; ABO MISMATCHED MARROW TRANSPLANTATION; RED BLOOD CELL APLASIA; ANTITHYMOCYTE GLOBULIN; CHRONIC LYMPHOCYTIC LEUKEMIA;

D O I：

10.3109/10428199309148522

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pure red cell aplasia was observed in a 28 year old woman following a major ABO mismatched allogeneic bone marrow transplant for chronic lymphocytic leukemia. No evidence of red blood cell production was observed for more than one year following transplant despite the absence of high isohemagglutinin titers. Treatment with antithymocyte globulin resulted in prompt restoration of reticulocytosis. Therapy with antithymocyte globulin should be considered in these instances when red cell aplasia follows mismatched allogeneic marrow transplantation.

引用

页码：169 / 171

页数：3

共 17 条

[1]

Bensinger W.I., Buckner C.D., Thomas E.D., Clift R.A., ABO-incompatible marrow transplants, Transplantation, 33, pp. 427-429, (1982)

[2]

Sniecinski I.J., Petz L.D., Oien L., Blume K.G., Immunohematologic problems arising from ABO incompatible bone marrow transplantation, Transplantation, XIX, pp. 4609-4611, (1987)

[3]

Braine H.G., Sensenbrenner L.L., Wright S.K., Tutschka P.J., Saral R., Santos G.W., Bone marrow transplantation with major Blood ABO Blood group incompatibility using erythrocyte depletion of marrow prior to infusion, Blood, 60, pp. 420-425, (1982)

[4]

Blacklock H.A., Prentice H.G., Evans J.P.M., Knight C.B.T., Gilmore M.J.M.L., Hazlehurst G.R.P., Ma D.D.F., Hoffbrand A.V., ABO-incompatible bone marrow transplantation: Removal of red Blood cells from donor marrow avoiding recipient antibody depletion, Lancet, II, pp. 1061-1064, (1982)

[5]

Marmont A.M., Frassoni F., Van Lint M.T., Podesta M., Lardan G., Occhini D., Piaggio G., Bachigalupo A., Isohemagglutinin induced pure red cell aplasia following major ABO incompatible marrow transplant for severe aplastic anemia. Resolution after plasma exchange, Experimental Hematology, 11, pp. 51-53, (1983)

[6]

Sniecinski I.J., Oien L., Petz L.D., Blume K.G., Immunohematologic consequences of major ABO-mismatched bone marrow transplantation, Transplantation, 45, pp. 530-534, (1988)

[7]

Barge A.J., Johnson G., Witherspoon R., Torok-Storb B., Antibody-mediated bone marrow failure after allogeneic bone marrow transplantation, Blood, 74, pp. 1477-1480, (1989)

[8]

Gmuir J.P., Burger J., Schaffner A., Neftel K., Oelz O., Frey D., Metaxas M., Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation, Blood, 75, pp. 290-295, (1990)

[9]

Messner H.A., Fauser A.A., Curtis J.E., Dotten D., Control of antibody-mediated pure red-cell aplasia by plamapheresis, New England Journal of Medicine, 22, pp. 1334-1338, (1981)

[10]

Sieff C., Bicknell D., Caine G., Robinson J., Lam G., Greaves M.F., Changes in cell surface antigen expression during hemopoietic differentiation, Blood, 60, pp. 703-713, (1982)

← 1 2 →